Pharmaceutical composition for preventing or treating brain cancer comprising compounds penetrating blood-brain barrier

摘要

The present invention relates to a pharmaceutical composition for preventing or treating brain cancer comprising a compound capable of passing through a blood-brain barrier as an active component. The pharmaceutical composition for preventing or treating brain cancer according to the present invention efficiently passes through the blood-brain barrier of a brain to effectively inhibit LRRK2 protein, thereby being able to be usefully used for preventing or treating brain cancer.